His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools
Moreover, the SURMOUNTMMO (tirzepatide, NCT05556512) will assess the impact of the dual GLP-1/GIP RA in cardiovascular outcomes and all-cause mortality for people with obesity (without diabetes) when the REDEFINE-3 study will assess the impact of cagrisema in people with obesity (with and without T2DM) and established cardiovascular disease
Great for meal planning and grocery planning
For an athlete whose performance depends on power, explosiveness, and strength, thats a real cost that may offset the body composition benefit entirely. This occurs, he said, because people on GLP-1s dont selectively burn fat
Properly substituted benzimidazoles as a new promising class of nicotinate phosphoribosyltransferase (NAPRT) modulators
Minimally, the average half-life in dogs was 4.0 +/- 0.7 minutes